Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Storm Therapeutics patents METTL3 inhibitors

Oct. 22, 2020

FDA grants full approval to Venclexta combinations for newly diagnosed AML

Oct. 21, 2020

Cardiff Oncology reports phase II results with onvansertib in mCRPC

Oct. 21, 2020

AstraZeneca discloses new PROTACs for cancer therapy

Oct. 21, 2020

PDAC subtypes point to targeting strategies

Oct. 21, 2020

New substudy evaluates Treadwell's CFI-400945 in metastatic CRPC

Oct. 20, 2020

Chinese researchers present new MAPK inhibitors

Oct. 20, 2020

Betta Pharmaceuticals patents EGFR mutant inhibitors

Oct. 20, 2020

Hinova Pharmaceuticals divulges new BRD4 and AR dual inhibitors

Oct. 20, 2020

Midatech presents phase I data for MTX-110 in diffuse intrinsic pontine glioma

Oct. 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...